PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression

INTRODUCTION: The role of chemotherapy alone in newly diagnosed WHO grade 2 oligodendroglioma after biopsy, incomplete or gross total resection remains controversial. We here analyze the clinical outcome of four patient cohorts being treated with either procarbazine, CCNU and vincristine (PCV) or te...

Descripción completa

Detalles Bibliográficos
Autores principales: Weller, Jonathan, Katzendobler, Sophie, Karschnia, Philipp, Lietke, Stefanie, Egensperger, Rupert, Thon, Niklas, Weller, Michael, Suchorska, Bogdana, Tonn, Joerg-Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211617/
https://www.ncbi.nlm.nih.gov/pubmed/33932195
http://dx.doi.org/10.1007/s11060-021-03765-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211617/
https://www.ncbi.nlm.nih.gov/pubmed/33932195
http://dx.doi.org/10.1007/s11060-021-03765-z

Ejemplares similares